Comparison of the efficacy of nifekalant and amiodarone in a porcine model of cardiac arrest

Resuscitation

Volumn 81, Issue 8, 2010, Pages 1031-1036

  Ji, Xian Fei ^a   Li, Chun Sheng ^a   Wang, Shuo ^a   Yang, Lin ^a   Cong, Lu Hong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Amiodarone; Cardiac arrest; Cardiopulmonary resuscitation; Nifekalant; Ventricular fibrillation

Indexed keywords

ADRENALIN; AMIODARONE; ANTIARRHYTHMIC AGENT; NIFEKALANT; PLACEBO; PYRIMIDINONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEFIBRILLATION; DRUG EFFICACY; EMERGENCY TREATMENT; EXPERIMENTAL MODEL; HEART ARREST; HEART FUNCTION; HEART VENTRICLE FIBRILLATION; HEMODYNAMIC MONITORING; NONHUMAN; PRIORITY JOURNAL; REPEATED DRUG DOSE; SURVIVAL RATE; SWINE; TREATMENT OUTCOME; ANIMAL; COMPARATIVE STUDY; COMPLICATION; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; HEART RATE; HEART VENTRICLE FUNCTION; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RESUSCITATION; VENTRICULAR FIBRILLATION;

AMIODARONE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CARDIOPULMONARY RESUSCITATION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART ARREST; HEART RATE; MALE; PYRIMIDINONES; SWINE; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION; VENTRICULAR FUNCTION;

EID: 77954760527     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2010.04.023     Document Type: Article

References (25)

1. Kudenchuck P.J., Cobb L.A., Copass M.K., Cummins R.O., Doherty A.M., Fahrenbruch C.E. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 1999, 341:871-878.
2. Dorian P., Cass D., Schwartz B., Cooper R., Gelaznikas R., Barr A. Amiodarone as compared with lidocaine for shock resistant ventricular fibrillation. N Engl J Med 2002, 346:884-890.
3. American Heart Association Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Part 7.2. Management of cardiac arrest. Circulation 2005, 112:IV58-IV66.
4. Nakaya H., T ohse N., Takeda Y., Kanno M. Effects of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes. Br J Pharmacol 1993, 109:157-163.
5. Shiga T., Tanaka K., Kato R., et al. Nifekalant versus lidocaine for in-hospital shock-resistant ventricular fibrillation or tachycardia. Resuscitation 2010, 81:47-52.
6. Murakawa Y., Yamashita T., Kanese Y., Omata M. Can a class III antiarrhythmic drug improve electrical defibrillation efficacy during ventricular fibrillation?. J Am Coll Cardiol 1997, 29:688-692.
7. Tahara Y., Kimura K., Kosuge M., et al. Comparison of nifekalant and lidocaine for the treatment of shock-refractory ventricular fibrillation. Circ J 2006, 70:442-446.
8. Katoh T., Mitamura H., Matsuda N., Takano T., Ogawa S., Kasanuki H. Emergency treatment with nifekalant, a novel class III anti-arrhythmic agent, for life-threatening refractory ventricular tachyarrhythmias. Post-marketing special investigation. Circ J 2005, 69:1237-1243.
9. Igarashi M., Fujino T., Toyoda M., et al. Defibrillation effects of nifekalant in patients with out-of-hospital ventricular fibrillation. Pacing Clin Electrophysiol 2005, 28:S155-157.
10. Baubin M., Rabl W., Pfeiffer K.P., Benzer A., Gilly H. Chest injuries after active compression-decompression cardiopulmonary resuscitation (ACD-CPR) in cadavers. Resuscitation 1999, 43:9-15.
11. El-Menyar A.A. The resuscitation outcome revisit the story of the stony heart. Chest 2005, 128:2835-2846.
12. Charlier R. Cardiac actions in the dog of a new antagonist of adrenergic eccitation which does not produce competitive blockade of adrenoceptors. Br J Pharmacol 1970, 39:668-674.
13. Somberg J.C., Cvetanovic I., Ranade V., Molnar J. Comparative effects of rapid bolus administration of aqueous amiodarone versus 10-minute cordarone i.v. infusion on mean arterial blood pressure. Cardiovasc Drugs Ther 2004, 18:345-351.
14. Paiva E.F., Perondi M.B., Kern K.B., et al. Effect of amiodarone on haemodynamics during cardiopulmonary resuscitation in a canine model of resistant ventricular fibrillation. Resuscitation 2003, 58:203-208.
15. Skrifvars M.B., Kuisma M., Boyd J., et al. The use of undiluted amiodarone in the management of out-of-hospital cardiac arrest. Acta Anaesthesiol Scand 2004, 48:582-587.
16. Petrovic T., Adnet F., Lapandry C. Successful resuscitation of ventricular fibrillation after low-dose amiodarone. Ann Emerg Med 1998, 32:518-519.
17. Levine J.H., Massumi A., Scheinman M.M., et al. Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group. J Am Coll Cardiol 1996, 27:67-75.
18. Anastasiou-Nana M.I., Nanas J.N., Nanas S.N., et al. Effects of amiodarone on refractory ventricular fibrillation in acute myocardial infarction: experimental study. J Am Coll Cardiol 1994, 23:253-258.
19. Tang W.C., Weil M.H., Sun S.J., Noc M., Yang L., Gazmuri R.J. Epinephrine increases the severity of postresuscitation myocardial dysfunction. Circulation 1995, 92:3089-3093.
20. Zhong J.Q., Dorian P. Epinephrine and vasopressin during cardiopulmonary resuscitation. Resuscitation 2005, 66:263-269.
21. Bassiakou E., Xanthos T., Koudouna E., et al. Atenolol in combination with epinephrine improves the initial outcome of cardiopulmonary resuscitation in a swine model of ventricular fibrillation. Am J Emerg Med 2008, 26:578-584.
22. Kowey P.R., Levine J.H., Herre J.M., et al. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing VT or fibrillation. Circulation 1995, 92:3255-3263.
23. Levine J.H., Massumi A., Scheinman M.M., et al. Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. J Am Coll Cardiol 1996, 27:67-75.
24. Kolettis T.M., Agelaki M.G., Baltogiannis G.G., et al. Comparative effects of acute vs. chronic oral amiodarone treatment during acute myocardial infarction in rats. Europace 2007, 9:1099-1104.
25. Katoh T., Tsunoo M., Mitsuhashi T., et al. Phase I study of MS-551(I): a single intravenous injection study. J Clin Ther Med 1997, 13:1659-1674. [in Japanese, English abstract].